4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-121363
President & CEO sold 2,170 shares at $13.58 ($29,469)
- President & CEO acquired 5,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-16 | Exercise or conversion : show line 1 in the form | +5,625 | $0.00 | $1 | 19,103 | D |
| 2016-05-17 | Sale : show line 2 in the form | −2,170 | $13.58 | $29,469 | 16,933 | D |
| Open-market sales · 2,170 sh · avg $13.58 · $29,469 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-16 | Returned to the company : show line 3 in the form Restricted Stock Unit | −5,625 | $0.00 | 2016-05-16 | 5,625 | 56,250 | D |
Loading xslF345X03/doc4.xml…